FDA Investigator Fabian Nchaparro Rodriguez

Fabian Nchaparro Rodriguez has conducted inspections on 114 sites in 1 countries as of 10 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
114
Last Inspection Date:
10 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100000454
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Fabian Nchaparro Rodriguez:
Abby Lmozeke Baker, Ademola O Daramola, Ana Delp Cintron, Ana P Barido, Andrew Saunders, Ann B Borromeo, Anna E Fain, Annette Melendez, Asad Ali, Asamoah Asamoah, Barbara D Wright, Barbara T Carmichael, Bonita S Chester, Brandon C Heitmeier, Brandy D Brown, Brentley S Collins, Brian L Belz, Brian R Yaun, Brian S Lynch, Brooke K Higgins, Burnell M Henry, Carl A Huffman, III, Carol F Robinson, Carrie L Doupnik, CDR Ileana Barreto Pettit, CDR Thomas R Berry, PPh, Cheryl G Scott, Cheryl L Watson, Chiaochun J Wang, Christopher J Adams, Clara E Santiago, Clendening, Cody D Rickman, Colleen C Kerr, Colleen M Aspinwall, Cordelia J Brammer, Craig A Garmendia, Craig T Rybus, Cynthia Jim, CSO, Cynthia L Medlin, Dana M Klimavicz, Dandan Wang, PhD, Daniel L Aisen, Danielle M Maddox, Dawn M Mccabe, Demario L Walls, Dennis L Doupnik, Dianiris C Ayala, Donna D Gallien, MPH, Douglas A Campbell, Dr. Gang Wang, PhD, Dyvette Arline, Edecia A Richards, Edward Deberry, Edward H Maticka, Eileen A Liu, Eileen J Bannerman, Emest F Bizjak, Emily E Smith, Eric L Dong, BS, Erica N Sandoval, Esra Toussaint, Francis A Guidry, Frank Flores, Gabriel R Mclemore, Gail L Katz, Gamal A Norton, George Pyramides, German Rivera, Gifford Whitehurst, Jr, Helen R Bester, Herbert M Corbello, Hultman, Ivan E Reyes, Jannet M Peroti, Jason D Abel, Jason F Chancey, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer M Menendez, Jessica Fields, Jessica L Pressley, Joanne E King, Jogy George, Johnathan M Crayton, Jonathan A Ferguson, Jonathan W Chapman, Juanelma H Palmer, Justin N Henson, Karen Gale Sego, Karen M Cooper, Kenneth L Smalls, Kenneth R Merritt, Kimberly Cdelk Brooks, Kip J Hanks, Konsuela Y Glass, Krista W Whitten, Lacey J Chessor, Laressa R Gray, Larry K Hampton, Laura E Garcia, Laura L Staples, Lawrence Harmon, Jr, LCDR Debra Emerson, LCDR Matthew R Mcnew, MPH, REHS/RS, LCDR Randall L Morris, Leena Thomas, Lesley K Satterwhite, Leslie W Gilbert, Libia M Lugo, Linda A Gregory Duty, Llopis, Marcus A Ray, Margaret E Slimbach, Maria V Price, Marshall H Kinsey, Melanie L Drayton, Melissa J Garcia, Michael J Schibi, Michael T Nehring, Miguel A Martinez Perez, Mizanne E Lewis, Myla T Collins, Nerming V Briones, Nicholas M Smith, Nicole A Lloyd, Omayra Nrodriguez Ruiz, Paula J Bretz, Penny H Mccarver, Qin Xu, R Edwadebey Deberry, Randy L Clarida, Raymond A Lyn, Jr, Rebecca Rodriguez, Richard J Bashay, Robert C Coleman, Robert D Tollefsen, Robert W Hudson, Ronnie E Jackson, Roy R Rinc, Sam Pepe, Sarah E Mcmullen, Scott A Watson, Scott T Ballard, Seneca D Toms, Sergio E Delgado, Shavon L Square, Shelton L Stribling, Sheri S Oliver, Shirhonda D Thorn, Shondra N Gipson, Simone E Pitts, Sonya M Edmonds, Stephanie D Crockett, Stephen G Mclane, Steven D Banks, Steven M Weinman, Susan M Corrales, Susan M Jackson, Susan M Turcovski, Susan T Hadman, Thomas B Smith, Thomas J Arista, Thomas R Withers, Toni M Booker, Toyin B Oladimeji, Traci M Armand, Travis E Chapman, Valerie Jgrecek Trinh, Veronica Fuentes, MS, Vesna V Stanoyevitch, Viviana Matta, Whitney M White, William F Lagud, Jr, Zhongren Wu

Fabian Nchaparro Rodriguez's Documents

Publish Date Document Type Title
May, 2022 FDA 483 Baxter Healthcare Corporation - Form 483, 2022-05-12
September, 2019 FDA 483 Choice Spine LLC - Form 483, 2019-09-30
July, 2018 FDA 483 Actavis Laboratories FL, Inc. - Form 483, 2018-07-19
March, 2022 FDA 483 Octapharma Plasma Inc - Form 483, 2022-03-24
August, 2019 FDA 483 American Blood Bank Corp. - Form 483, 2019-08-07
January, 2020 FDA 483 Blood Assurance Inc. - Form 483, 2020-01-17
February, 2018 EIR Barr Laboratories Inc. - EIR, 2018-02-28
July, 2021 FDA 483 Medic Inc - Form 483, 2021-07-27
February, 2019 FDA 483 Blood Assurance Inc - Form 483, 2019-02-15
April, 2019 FDA 483 Physician's Plasma Alliance Inc. dba Biological Specialty Company dba - Form 483, 2019-04-12
May, 2023 FDA 483 Lux Therapeutics LLC - Form 483, 2023-05-12
February, 2020 FDA 483 American Red Cross Blood Svcs - Form 483, 2020-02-27
February, 2020 FDA 483 Response American Red Cross Blood Svcs - Form 483R, 2020-03-19
March, 2022 FDA 483 Alon Medical Technology, LLC - Form 483, 2022-03-31
April, 2023 FDA 483 Blood Connection Inc. (The) - Form 483, 2023-04-04
February, 2018 FDA 483 Barr Laboratories Inc. - Form 483, 2018-02-28
March, 2022 FDA 483 Octapharma Plasma Inc - Form 483, 2022-03-04
September, 2019 FDA 483 Innovative Transfusion Medicine, Inc. - Form 483, 2019-09-19
July, 2024 FDA 483 Continental Services Group, Inc. - Form 483, 2024-07-24
May, 2023 EIR Lux Therapeutics LLC - EIR, 2023-06-02
September, 2024 FDA 483 Fertility Center LLC - Form 483, 2024-09-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more